alkenes has been researched along with B16 Melanoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Azam, MS; Choi, J; Kim, HR; Kwon, M | 1 |
Bezerra, DP; Bomfim, LM; Campos, AF; Costa, EV; Dias, RB; Menezes, LR; Nascimento, MP; Neto, AF; Rocha, CA; Rodrigues, AC; Silva, LC; Soares, MB | 1 |
2 other study(ies) available for alkenes and B16 Melanoma
Article | Year |
---|---|
Sargaquinoic acid ameliorates hyperpigmentation through cAMP and ERK-mediated downregulation of MITF in α-MSH-stimulated B16F10 cells.
Topics: Alkenes; alpha-MSH; Animals; Benzoquinones; Cell Line, Tumor; Cyclic AMP; Cyclic AMP Response Element-Binding Protein; Cyclic AMP-Dependent Protein Kinases; Down-Regulation; Hyperpigmentation; Intramolecular Oxidoreductases; Melanins; Melanoma, Experimental; Mice; Microphthalmia-Associated Transcription Factor; Mitogen-Activated Protein Kinases; Monophenol Monooxygenase; Oxidoreductases; Phosphorylation; Quality of Life; Signal Transduction | 2018 |
Antitumour Activity of the Microencapsulation of Annona vepretorum Essential Oil.
Topics: Acyclic Monoterpenes; Adult; Alkenes; Animals; Annona; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Bicyclic Monoterpenes; Cell Line, Tumor; Cyclohexane Monoterpenes; Cyclohexanones; Disease Models, Animal; Drug Compounding; Gas Chromatography-Mass Spectrometry; Hep G2 Cells; Humans; Inhibitory Concentration 50; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Monoterpenes; Oils, Volatile; Plant Leaves; Sesquiterpenes; Sesquiterpenes, Germacrane; Terpenes; Young Adult | 2016 |